CX4152

CAS No. 333351-27-2

CX4152( CX 4152 | CX-4152 )

Catalog No. M14121 CAS No. 333351-27-2

A novel potent, selective CXCR2 inhibitor with IC50 of 7.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CX4152
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent, selective CXCR2 inhibitor with IC50 of 7.6 nM.
  • Description
    A novel potent, selective CXCR2 inhibitor with IC50 of 7.6 nM; displays>1,000-fold selectivity over CXCR4 (IC50>50 uM); inhibits CXCR2 signaling through downregulation of surface CXCR2; significantly inhibits CXCL8-mediated neutrophil migration and LPS-induced lung inflammation in mice; inhibits CXCR2/β-arrestin-2 association, cell migration and proliferation, and acute inflammation in mouse models.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CX 4152 | CX-4152
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    333351-27-2
  • Formula Weight
    435.538
  • Molecular Formula
    C25H25NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1=C(C2=C(O1)C3=CC=CC=C3C(=C2)NS(=O)(=O)C4=CC=C(C=C4)C(C)(C)C)C(=O)C
  • Chemical Name
    N-(3-acetyl-2-methylnaphtho[1,2-b]furan-5-yl)-4-(tert-butyl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ha H, et al. J Chem Inf Model. 2015 Aug 24;55(8):1720-38.
molnova catalog
related products
  • CX815

    A novel potent, selective CXCR2 inhibitor with IC50 of 0.4 nM.

  • Elubrixin tosylate

    Elubrixin (SB-656933) is a potent, selective, competitive and reversible CXCR2 antagonist.

  • PF-04136309

    PF-4136309 (INCB8761) is a potent, selective, competitive, reversible full CCR2 antagonist with IC50 of 2-5 nM.